225 related items for PubMed ID: 18218301
21. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM, Mendoza SA.
J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
[Abstract] [Full Text] [Related]
22. Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome.
Tanaka H, Nakahata T, Ito E.
Pediatr Nephrol; 2004 Sep; 19(9):1055-8. PubMed ID: 15160285
[Abstract] [Full Text] [Related]
23. Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study.
Sheashaa H, Mahmoud I, El-Basuony F, El-Husseini A, Hassan N, El-Baz M, Ahmed NS, Sobh M.
Int Urol Nephrol; 2007 Sep; 39(3):923-8. PubMed ID: 17447154
[Abstract] [Full Text] [Related]
24. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B, Ossman MI, Sheriff S.
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[Abstract] [Full Text] [Related]
25. Benefits of once-daily administration of cyclosporine a for children with steroid-dependent, relapsing nephrotic syndrome.
Suzuki K, Oki E, Tsuruga K, Aizawa-Yashiro T, Ito E, Tanaka H.
Tohoku J Exp Med; 2010 Mar; 220(3):183-6. PubMed ID: 20208412
[Abstract] [Full Text] [Related]
26. Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood.
Neuhaus TJ, Burger HR, Klingler M, Fanconi A, Leumann EP.
Eur J Pediatr; 1992 Oct; 151(10):775-8. PubMed ID: 1425802
[Abstract] [Full Text] [Related]
27. Cyclosporin-A in the treatment of nephrotic syndrome: the importance of monitoring C0 (trough) and C2 (two hours after its administration) blood levels.
Goumenos DS, Kalliakmani P, Tsakas S, Savidaki I, Vlachojannis JG.
Med Chem; 2006 Jul; 2(4):391-3. PubMed ID: 16848751
[Abstract] [Full Text] [Related]
28. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
29. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
30. Cyclosporine therapy in steroid-dependent or steroid-resistant idiopathic focal and segmental glomerulosclerosis.
Gorsane I, Helal I, Yacoub I, Hamida FB, Abderrahim E, Abdallah TB.
Saudi J Kidney Dis Transpl; 2016 Mar; 27(5):958-965. PubMed ID: 27752004
[Abstract] [Full Text] [Related]
31. Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis.
el-Husseini A, el-Basuony F, Mahmoud I, Donia A, Hassan N, Sayed-Ahmad N, Sobh M.
Pediatr Nephrol; 2004 Sep; 19(9):976-81. PubMed ID: 15241676
[Abstract] [Full Text] [Related]
32. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, Kaneko K, Yamashiro Y.
Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
[Abstract] [Full Text] [Related]
33. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
Nephrol Dial Transplant; 1993 Dec; 8(12):1326-32. PubMed ID: 8159300
[Abstract] [Full Text] [Related]
34. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.
Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G.
Pediatr Nephrol; 2005 Jan; 20(1):25-9. PubMed ID: 15602664
[Abstract] [Full Text] [Related]
35. Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome.
Fujinaga S, Hirano D, Murakami H, Ohtomo Y, Shimizu T, Kaneko K.
Pediatr Nephrol; 2012 Apr; 27(4):671-4. PubMed ID: 22198072
[Abstract] [Full Text] [Related]
36. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K, Słowiaczek E, Kwinta-Rybicka J, Wilkosz K, Drozdz D, Nowak J.
Przegl Lek; 1996 Apr; 53(4):365-8. PubMed ID: 8711193
[Abstract] [Full Text] [Related]
37. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[Abstract] [Full Text] [Related]
38. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
39. Single daily dose of cyclosporine in patients with primary glomerulonephritis and nephrotic syndrome.
Rasche FM, Keller F, Kunze G, Boesler B, Czock D.
Clin Nephrol; 2007 May; 67(5):285-92. PubMed ID: 17542337
[Abstract] [Full Text] [Related]
40. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
Cao Q, Huang WY, Xu H, Zhou LJ.
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):698-701. PubMed ID: 19099862
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
